Stefania De Chiara, Francesca Olmeo, Emanuela Andretta, Luca De Simone Carone, Marcello Mercogliano, Vlada S. Belova, Lyudmila A. Romanenko, Maxim S. Kokoulin, Alba Silipo, Antonio Molinaro and Flaviana Di Lorenzo
{"title":"Signals from the sea: the structural peculiarity of lipid A and weak immunostimulatory lipopolysaccharide from Rheinheimera japonica†","authors":"Stefania De Chiara, Francesca Olmeo, Emanuela Andretta, Luca De Simone Carone, Marcello Mercogliano, Vlada S. Belova, Lyudmila A. Romanenko, Maxim S. Kokoulin, Alba Silipo, Antonio Molinaro and Flaviana Di Lorenzo","doi":"10.1039/D5CB00134J","DOIUrl":null,"url":null,"abstract":"<p >Lipopolysaccharides (LPSs) isolated from marine bacteria represent a valuable resource for biomedical innovation. Here, we report the first structural elucidation of the lipid A moiety and a preliminary immunological assessment of the full LPS from the marine Gram-negative <em>Rheinheimera japonica</em> KMM 9513<small><sup>T</sup></small>. Using MALDI-TOF mass spectrometry (MS) and tandem MS, we show that the lipid A from <em>R. japonica</em> KMM 9513<small><sup>T</sup></small> exhibits a heterogeneous architecture, composed of <em>mono</em>- and <em>bis</em>-phosphorylated tetra- and penta-acylated species with variations in the acyl chain length, saturation, branching, and positional isomerism. Functionally, the full LPS was found to be immunologically silent toward TLR4-mediated NF-κB activation in HEK-Blue™ hTLR4 cells and triggered only modest, dose-dependent responses in differentiated human THP-1 macrophages. Strikingly, the <em>R. japonica</em> LPS was able to antagonize <em>E. coli</em> LPS-induced TLR4 activation, even at low doses. Overall, this study uncovers a structurally and functionally atypical marine LPS with a dual profile, inactive towards TLR4 yet capable of modulating LPS-induced signaling. These findings offer a promising basis to consider <em>R. japonica</em> LPS as a source of structural inspiration for the design of synthetic derivatives with controlled immunological properties.</p>","PeriodicalId":40691,"journal":{"name":"RSC Chemical Biology","volume":" 9","pages":" 1414-1425"},"PeriodicalIF":3.1000,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12268950/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"RSC Chemical Biology","FirstCategoryId":"1085","ListUrlMain":"https://pubs.rsc.org/en/content/articlelanding/2025/cb/d5cb00134j","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Lipopolysaccharides (LPSs) isolated from marine bacteria represent a valuable resource for biomedical innovation. Here, we report the first structural elucidation of the lipid A moiety and a preliminary immunological assessment of the full LPS from the marine Gram-negative Rheinheimera japonica KMM 9513T. Using MALDI-TOF mass spectrometry (MS) and tandem MS, we show that the lipid A from R. japonica KMM 9513T exhibits a heterogeneous architecture, composed of mono- and bis-phosphorylated tetra- and penta-acylated species with variations in the acyl chain length, saturation, branching, and positional isomerism. Functionally, the full LPS was found to be immunologically silent toward TLR4-mediated NF-κB activation in HEK-Blue™ hTLR4 cells and triggered only modest, dose-dependent responses in differentiated human THP-1 macrophages. Strikingly, the R. japonica LPS was able to antagonize E. coli LPS-induced TLR4 activation, even at low doses. Overall, this study uncovers a structurally and functionally atypical marine LPS with a dual profile, inactive towards TLR4 yet capable of modulating LPS-induced signaling. These findings offer a promising basis to consider R. japonica LPS as a source of structural inspiration for the design of synthetic derivatives with controlled immunological properties.